Doximity (NASDAQ:DOCS) Director Sells $354,200.00 in Stock

Doximity, Inc. (NASDAQ:DOCS) Director Regina Benjamin sold 5,000 shares of the business’s stock in a transaction that occurred on Friday, October 10th. The shares were sold at an average price of $70.84, for a total value of $354,200.00. Following the completion of the sale, the director owned 19,839 shares of the company’s stock, valued at $1,405,394.76. The trade was a 20.13% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link.

Doximity Stock Performance

Shares of NASDAQ DOCS opened at $67.27 on Friday. The firm has a market capitalization of $12.60 billion, a price-to-earnings ratio of 67.27, a PEG ratio of 4.10 and a beta of 1.38. The stock has a 50 day moving average price of $69.20 and a 200 day moving average price of $61.18. Doximity, Inc. has a 52-week low of $40.87 and a 52-week high of $85.21.

Doximity (NASDAQ:DOCS) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.The firm’s revenue for the quarter was up 15.2% compared to the same quarter last year. During the same period last year, the business earned $0.28 earnings per share. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Analysts forecast that Doximity, Inc. will post 0.99 earnings per share for the current year.

Hedge Funds Weigh In On Doximity

Several hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. boosted its holdings in Doximity by 8.8% in the first quarter. Vanguard Group Inc. now owns 12,194,492 shares of the company’s stock valued at $707,646,000 after purchasing an additional 990,923 shares during the last quarter. William Blair Investment Management LLC boosted its stake in shares of Doximity by 13.8% during the 2nd quarter. William Blair Investment Management LLC now owns 5,219,394 shares of the company’s stock worth $320,158,000 after acquiring an additional 634,927 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Doximity by 7.7% during the 2nd quarter. Geode Capital Management LLC now owns 3,639,898 shares of the company’s stock worth $223,829,000 after acquiring an additional 261,319 shares in the last quarter. Franklin Resources Inc. boosted its stake in shares of Doximity by 53.9% during the 2nd quarter. Franklin Resources Inc. now owns 3,162,593 shares of the company’s stock worth $193,993,000 after acquiring an additional 1,108,162 shares in the last quarter. Finally, Invesco Ltd. boosted its stake in shares of Doximity by 54.8% during the 1st quarter. Invesco Ltd. now owns 1,969,326 shares of the company’s stock worth $114,280,000 after acquiring an additional 696,923 shares in the last quarter. 87.19% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

DOCS has been the subject of a number of recent research reports. Robert W. Baird boosted their price objective on shares of Doximity from $75.00 to $80.00 and gave the stock an “outperform” rating in a research note on Thursday, September 11th. Zacks Research downgraded shares of Doximity from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 20th. Bank of America upped their price target on Doximity from $55.00 to $62.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 25th. Truist Financial upped their price target on Doximity from $52.00 to $61.00 and gave the stock a “hold” rating in a research report on Thursday, July 17th. Finally, The Goldman Sachs Group set a $64.00 price target on Doximity and gave the stock a “sell” rating in a research report on Wednesday, October 1st. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, nine have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $69.37.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.